ZFP90 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.204300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.114200E-02
Normal-vs-Stage2
3.265800E-02
Normal-vs-Stage3
1.164300E-02
Normal-vs-Stage4
7.510600E-01
Stage1-vs-Stage2
7.706800E-01
Stage1-vs-Stage3
1.178250E-01
Stage1-vs-Stage4
1.885030E-01
Stage2-vs-Stage3
1.787400E-01
Stage2-vs-Stage4
5.334200E-02
Stage3-vs-Stage4
5.483900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.270500E-02
Normal-vs-AfricanAmerican
6.507700E-02
Normal-vs-Asian
4.460800E-03
Caucasian-vs-AfricanAmerican
8.391600E-01
Caucasian-vs-Asian
2.508300E-02
AfricanAmerican-vs-Asian
1.888790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.929900E-02
Normal-vs-Female
4.115800E-02
Male-vs-Female
9.204200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.381500E-02
Normal-vs-Age(41-60Yrs)
7.513700E-02
Normal-vs-Age(61-80Yrs)
3.854300E-02
Normal-vs-Age(81-100Yrs)
1.995680E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.263800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.065000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.468200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.953900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.155380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.078600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.921600E-03
Normal-vs-Daily Drinker
7.203300E-04
Normal-vs-Weekly Drinker
2.907700E-02
Normal-vs-Occasional Drinker
2.658600E-01
Normal-vs-Social Drinker
1.870640E-01
Non Drinker-vs-Daily Drinker
6.851600E-01
Non Drinker-vs-Weekly Drinker
7.154800E-01
Non Drinker-vs-Occasional Drinker
1.639850E-02
Non Drinker-vs-Social Drinker
5.543600E-02
Daily Drinker-vs-Weekly Drinker
4.621800E-01
Daily Drinker-vs-Occasional Drinker
1.057500E-02
Daily Drinker-vs-Social Drinker
3.898400E-02
Weekly Drinker-vs-Occasional Drinker
1.044170E-01
Weekly Drinker-vs-Social Drinker
2.063000E-01
Occasional Drinker-vs-Social Drinker
7.309600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.598000E-02
Normal-vs-Grade 2
3.443000E-03
Normal-vs-Grade 3
4.764000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.895170E-01
Grade 1-vs-Grade 3
7.642200E-02
Grade 1-vs-Grade 4
3.598000E-02
Grade 2-vs-Grade 3
3.263200E-01
Grade 2-vs-Grade 4
3.443000E-03
Grade 3-vs-Grade 4
4.764000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.307700E-02
Normal-vs-NonDiabetic
2.339900E-02
Diabetic-vs-NonDiabetic
9.430200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.450080E-02
Normal-vs-NoPancreatitis
3.125800E-02
Pancreatitis-vs-NoPancreatitis
7.449600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.335700E-02
Normal-vs-N1
3.442200E-02
N0-vs-N1
8.299000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.232370E-01
Normal-vs-TP53-NonMutant
1.418570E-01
TP53-Mutant-vs-TP53-NonMutant
8.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
